A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer
Clinical trial NCT05504213 · UNKNOWN
Trial details
- NCT number
- NCT05504213
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-12
- Primary completion
- 2023-07-31
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.